<img height="1" width="1" src="https://www.facebook.com/tr?id=841180246705289&amp;ev=PageView &amp;noscript=1">

We measure our impact by patient outcomes and the success of our partners. Learn More 

Dascena exhibits at the AHA Scientific Sessions in Anaheim, California

November 12, 2017

Between December 2016 and February 2017, Dascena tested sepsis prediction algorithm InSight in a randomized clinical trial at UCSF Medical Center. Analysis of the results proved InSight’s superiority to commonly used scoring systems, such as Systemic Inflammatory Response Syndrome (SIRS) and Modified Early Warning System (MEWS), and improved patient outcomes, including a 58% reduction in patient mortality. These and other results were presented at the American Heart Association (AHA) Scientific Sessions in Anaheim, California, showcasing the first positive performance of a machine learning-based sepsis screening tool in a randomized clinical trial.

Interested in learning more?

Proud sponsor of Sepsis Alliance